Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Discover the pros and cons of long term versus short term investing. Make informed decisions based on your financial goals.
28,015 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Oil futures rose late Thursday as tensions in the Persian Gulf flared again, while stock-market futures were muted af...
A key chart pattern has flipped bullish for altcoins, with analysts arguing it mirrors setups that preceded massive r...
IBM led a narrow rally in a mixed tech session, jumping 8% while Oracle, Cisco, and HPE drifted. The move raises ques...
XRP spot ETFs posted solid inflows in May, while Bitcoin ETFs endured a multiday outflow stretch, signaling a shift i...
A reported breakthrough on Iran negotiations sparked a risk-on market rally and shifted bets on the Federal Reserve's...
Bitcoin holds near the $64,000 level as major altcoins pause, pointing to a broader market consolidation. Ethereum si...
Strategy pauses bitcoin buys as the firm unveils a $1 billion digital credit repurchase program, boosting cash reserv...
A New York judge denied Kalshi’s bid for an injunction, keeping state gambling laws in play as federal rulemaking on ...
Global container rates surge again amid geopolitical tension and tariff uncertainty, reviving concerns about another ...
The S&P 500 nudged higher as traders brace for a pivotal Federal Reserve policy decision. Investors weigh rate paths,...
Bitcoin ETFs swung from net outflows to inflows in late February, signaling a potential shift in institutional demand...